Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT07210437 · ClinicalTrials.gov registry record · NA
Longitudinal Autonomic Characterization as a Predictor for Secondary Medical Complications Post-SCI
A NA study of Spinal Cord Injuries, sponsored by Mayo Clinic.
- Recruiting
- Registry status
- NA
- Development phase
- 18
- Enrollment target
- 1
- Study location
NCT07210437: Recruiting NA study of Spinal Cord Injuries, sponsored by Mayo Clinic.
NCT07210437 is a NA study of Spinal Cord Injuries that is actively recruiting participants, run by Mayo Clinic. The registered enrollment target is 18 participants, below the 62-participant average among 202 other Spinal Cord Injuries trials with a reported enrollment target (71% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT07210437, a NA study of Spinal Cord Injuries, is actively recruiting participants, sponsored by Mayo Clinic.
- RECRUITING
- Registry status
- NA
- Development phase
- 18 participants
- Enrollment target
- 1
- Study location
Study Summary
The purpose of this research is to learn about how the body is able to balance changes in blood pressure, how that changes over time, and how these changes impact a participant's risk of developing medical problems.
Primary Outcome
Presence or absence of phase II on Valsalva maneuver testing, which takes approximately 15 seconds to complete. This will be repeated x3.
Conditions Studied
Interventions
- DIAGNOSTIC_TEST Tests of sympathetic inhibition
- DIAGNOSTIC_TEST Tests of above level sympathetic activation
- DIAGNOSTIC_TEST Testing of below level sympathetic activation
Study Locations (1)
Minnesota
- Mayo Clinic - Rochester
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 18 participants |
| Start Date | 2026-01-31 |
| Est. Completion | 2028-06-01 |
| Phase | NA |
What NCT07210437 shows while recruiting
NCT07210437 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 18 participants, a relatively small participant target, below the 62-participant average among 202 other Spinal Cord Injuries trials with a reported enrollment target (71% lower).
The record links to 1 condition, with Spinal Cord Injuries appearing as the primary indexed condition, and to 3 interventions - of which Tests of sympathetic inhibition is the first listed.
NCT07210437 reports a single indexed study location in Minnesota.
Frequently Asked Questions
What is clinical trial NCT07210437 about?
NCT07210437 is a clinical study titled "Longitudinal Autonomic Characterization as a Predictor for Secondary Medical Complications Post-SCI". The purpose of this research is to learn about how the body is able to balance changes in blood pressure, how that changes over time, and how these changes impact a participant's risk of developing medical problems.
What is the current status of trial NCT07210437?
This trial is currently recruiting. It is a NA study. The enrollment target is 18 participants. The study started on 2026-01-31. Estimated completion is 2028-06-01.
What conditions does trial NCT07210437 study?
This clinical trial studies the following conditions: Spinal Cord Injuries.
What interventions are being tested in trial NCT07210437?
The interventions under investigation include: Tests of sympathetic inhibition (DIAGNOSTIC_TEST), Tests of above level sympathetic activation (DIAGNOSTIC_TEST), Testing of below level sympathetic activation (DIAGNOSTIC_TEST).
Who is sponsoring clinical trial NCT07210437?
This trial is sponsored by Mayo Clinic, which has 2,844 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT07210437 being conducted?
This trial has 1 study location across Minnesota. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Spinal Cord Injuries
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT07210437's enrollment target sits among peer trials
18 139th of 202 higher than 61 of 202 other Spinal Cord Injuries trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Spinal Cord Injuries trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Feasibility of the BrainGate2 Neural Interface System in Persons With Tetraplegia (BG-Speech-02)
RECRUITING · NA
-
Closed-loop Spinal Stimulation for Restoration of Upper Extremity Function After Spinal Cord Injury
RECRUITING · NA
-
Neuromodulation to Improve Respiratory Function in Cervical Spinal Cord Injury
RECRUITING · NA
-
Transcutaneous Spinal Stimulation and Exercise for Locomotion
RECRUITING · NA
-
HAPPINESS: cHAnging the Perceived Pain INtEnSity in Populations With Spinal Cord Injury and With Health Disparities: A Feasibility Study
RECRUITING · NA
-
Dosing rTMS for Depression Post-SCI
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01245179 · 18 participants · Phase 1
Study of Panobinostat (LBH589) in Patients With Sickle Cell Disease
- NCT01999361 · 18 participants · NA
Prevention of de Novo Allosensitization in Islet Transplant Recipients Following Complete Graft Loss
- NCT02359825 · 18 participants · Phase 1
Nerve Repair Using Hydrophilic Polymers to Promote Immediate Fusion of Severed Axons and Swift Return of Function
- NCT02870244 · 18 participants · Phase 1
Adoptive T Cell Immunotherapy for Advanced Melanoma Using Engineered Lymphocytes
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT06358040 · started 2026-10 · NA
Opioid Dispenser for Microdiscectomy/Laminectomy